Evidence map›Paper›PMID 39153109›Full record

ArticleVirchows Archiv : an international journal of pathology2025

Patients ask and pathologists answer: ten questions around prostate cancer grading.

Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Carmine Franzese, Gianluca Giannarini, Alessandro Crestani, Eamonn T Rogers, Rodolfo Montironi

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Urologists, pathologists and patient advocates in prostate cancer shared decision-making.Virchows Archiv : an international journal of pathology · 2026
    Article
  3. Urologists and pathologists in prostate cancer screening.Virchows Archiv : an international journal of pathology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessia CimadamoreInstitute of Pathological Anatomy, Department of Medicine, University of Udine, Udine, Italy.
Liang ChengDepartment of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, Lifespan Health, and the Legorreta Cancer Center at Brown University, Providence, RI, USA.
Antonio Lopez-BeltranDepartment of Surgery, Cordoba University Medical School, Cordoba, Spain.
Carmine FranzeseUrology Unit, University Hospital, Ospedale Santa Maria Della Misericordia, Udine, Italy.
Gianluca GiannariniUrology Unit, University Hospital, Ospedale Santa Maria Della Misericordia, Udine, Italy.
Alessandro CrestaniUrology Unit, University Hospital, Ospedale Santa Maria Della Misericordia, Udine, Italy.
Eamonn T RogersDepartment of Urology, National University of Ireland Galway, Galway, Ireland.
Rodolfo MontironiMolecular Medicine and Cell Therapy Foundation, c/o Polytechnic University of the Marche Region, Via Tronto 10, 60126, Ancona, Italy. rodolfo.montironi51@gmail.com.ORCID http://orcid.org/0000-0003-3938-610X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathologists have closely collaborated with clinicians, mainly urologists, to update the Gleason grading system to reflect the current practice and approach in prostate cancer diagnosis, prognosis, and treatment. This has led to the development of what is called patient advocacy and patient information. Ten common questions asked by patients to pathologists concerning PCa grading and the answers given by the latter are reported.

Indexed as

Neoplasm GradingPathologistsProstatic NeoplasmsHumansMalePatient AdvocacyPrognosisGleason scoreGrade groupPatient advocacyPatient informationProstate cancerUropathology

Identifiers

PMID39153109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.